Incompatibility of Vancomycin and Ceftazidime for Intraperitoneal Use

Keane W.F. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. , Holmes C.J. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update (Published erratum appears in Perit Dial Int 2000; 20: 828–9). Perit Dial Int 2000; 20: 396–411.

Fiscella R.G. Physical incompatibility of vancomycin and ceftazidime for intravitreal injection (Letter). Arch Ophthalmol 1993; 111: 730.

Lifshitz T. , Lapid–Gortzak R. , Finkelman Y. , Klemperer I. Vancomycin and ceftazidime incompatibility upon intravitreal injection (Letter). Br J Ophthalmol 2000; 84: 117.

Gahart B.L. Ceftazidime. In: Intravenous medications: a handbook for nurses and allied health professionals, 11th ed. St. Louis, MO: Mosby, 1995: 136–8.

Cairns C.J. , Robertson J. Incompatibility of ceftazidime and vancomycin. Pharm J 1987; 238: 577.

Trissel L.A. Vancomycin HCl. In: Handbook on injectable drugs, 11th ed. Bethesda, MD: American Society of Health-System Pharmacists, 2001: 1273–85.

McEvoy G.K. , ed. AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists, 1999.

GlaxoSmithKline. Ceptaz (ceftazidime L-arginine formulation) package insert. Research Triangle Park, NC: GlaxoSmithKline, 1998.

Trissel L.A. , Gilbert D.L. , Martinez J.F. Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Hosp Pharm 1999; 33: 1515–22.

Vaughan L.M. , Poon C.Y. Stability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solution. Ann Pharmacother 1994; 28: 572–6.

Stamatakis M.K. , Leader W.G. , Tracy T.S. Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions. Am J Health Syst Pharm 1999; 56: 246–8.